Revenue Recognition - Disaggregation of Revenue (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2021	Sep. 30, 2020	Sep. 30, 2021	Sep. 30, 2020
Disaggregation of Revenue [Line Items]
Total revenues	$ 36,769	$ 18,385	$ 80,253	$ 48,023
Americas
Disaggregation of Revenue [Line Items]
Total revenues	7,816	5,841	18,588	17,972
EMEA
Disaggregation of Revenue [Line Items]
Total revenues	4,685	4,889	17,135	14,175
APAC
Disaggregation of Revenue [Line Items]
Total revenues	24,268	7,655	44,530	15,876
Product revenue
Disaggregation of Revenue [Line Items]
Total revenues	28,731	8,401	53,674	18,005
Research and development revenue
Disaggregation of Revenue [Line Items]
Total revenues	8,038	9,984	26,579	30,018
Performance Enzymes
Disaggregation of Revenue [Line Items]
Total revenues	32,584	13,005	68,397	31,385
Performance Enzymes | Americas
Disaggregation of Revenue [Line Items]
Total revenues	5,999	3,209	12,573	7,381
Performance Enzymes | EMEA
Disaggregation of Revenue [Line Items]
Total revenues	2,317	2,141	11,294	8,128
Performance Enzymes | APAC
Disaggregation of Revenue [Line Items]
Total revenues	24,268	7,655	44,530	15,876
Performance Enzymes | Product revenue
Disaggregation of Revenue [Line Items]
Total revenues	28,731	8,401	53,674	18,005
Performance Enzymes | Research and development revenue
Disaggregation of Revenue [Line Items]
Total revenues	3,853	4,604	14,723	13,380
Novel Biotherapeutics
Disaggregation of Revenue [Line Items]
Total revenues	4,185	5,380	11,856	16,638
Novel Biotherapeutics | Americas
Disaggregation of Revenue [Line Items]
Total revenues	1,817	2,632	6,015	10,591
Novel Biotherapeutics | EMEA
Disaggregation of Revenue [Line Items]
Total revenues	2,368	2,748	5,841	6,047
Novel Biotherapeutics | APAC
Disaggregation of Revenue [Line Items]
Total revenues	0	0	0	0
Novel Biotherapeutics | Product revenue
Disaggregation of Revenue [Line Items]
Total revenues	0	0	0	0
Novel Biotherapeutics | Research and development revenue
Disaggregation of Revenue [Line Items]
Total revenues	$ 4,185	$ 5,380	$ 11,856	$ 16,638